Literature DB >> 3431817

Contrast sensitivity in multiple sclerosis. A study in 35 patients with and without optic neuritis.

J P Nordmann1, H Saraux, E Roullet.   

Abstract

Binocular and monocular contrast sensitivity (CS) functions were determined for 35 patients with multiple sclerosis (MS) of whom only 21 had a history of optic neuritis. CS was abnormal in all 21 of these patients; alterations of CS affected all spatial frequencies, not only for the eye with optic neuritis, but also for the clinically unaffected eye (p less than 0.01). Approximately one third of the 14 patients with MS but without any history of past visual disturbances showed an optic nerve involvement. Our results show that (1) clinically visual impairment is bilateral, even if optic neuritis seems unilateral, and (2) CS can detect silent lesions of the visual pathways in MS and may prove to be more sensitive than visual evoked potentials.

Entities:  

Mesh:

Year:  1987        PMID: 3431817     DOI: 10.1159/000309813

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  8 in total

1.  Visual function in multiple sclerosis.

Authors:  B Ashworth; P A Aspinall; J D Mitchell
Journal:  Doc Ophthalmol       Date:  1989-11       Impact factor: 2.379

2.  Detection of hidden visual loss in multiple sclerosis. A comparison of pattern-reversal visual evoked potentials and contrast sensitivity.

Authors:  M J Leys; C M Candaele; A F De Rouck; J V Odom
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

3.  Measuring contrast sensitivity in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.

Authors:  R De Marco; G Ambrosio; G Ferrara
Journal:  Doc Ophthalmol       Date:  2000-09       Impact factor: 2.379

4.  Contrast sensitivity function in Graves' ophthalmopathy and dysthyroid optic neuropathy.

Authors:  M S Suttorp-Schulten; R Tijssen; M P Mourits; P Apkarian
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

5.  Contrast Sensitivity versus Visual Evoked Potentials in Multiple Sclerosis.

Authors:  Javad Heravian Shandiz; Abbas Nourian; Mercedeh Bahr Hossaini; Hadi Ostadi Moghaddam; Abbas-Ali Yekta; Laleh Sharifzadeh; Parviz Marouzi
Journal:  J Ophthalmic Vis Res       Date:  2010-07

6.  Contrast sensitivity of thyroid associated ophthalmopathy patients without obvious optic neuropathy.

Authors:  Ümit Beden; Sümeyra Kaya; Volkan Yeter; Dilek Erkan
Journal:  ScientificWorldJournal       Date:  2013-12-24

7.  The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders: Evaluation of psychometric features in a community sample.

Authors:  Famke Huizinga; Joost Heutink; Gera A de Haan; Iris van der Lijn; Fleur E van der Feen; Anne C L Vrijling; Bart J M Melis-Dankers; Stefanie M de Vries; Oliver Tucha; Janneke Koerts
Journal:  PLoS One       Date:  2020-04-29       Impact factor: 3.240

8.  Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis.

Authors:  Jennifer Graves; Steven L Galetta; Jeffrey Palmer; David H Margolin; Marco Rizzo; John Bilbruck; Laura J Balcer
Journal:  Mult Scler       Date:  2013-03-04       Impact factor: 6.312

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.